Skip to content

Hypertension, Ethnicity and Exercise Trial

Hypertension, Ethnicity and Exercise Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06824805
Acronym
HYPE2X
Enrollment
60
Registered
2025-02-13
Start date
2020-06-01
Completion date
2023-11-30
Last updated
2025-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The main aim of this study is to investigate the acute effects of a single bout of isometric handgrip exercise (IHG) and a single bout of aerobic endurance exercise (AEX) on blood pressure, both immediately after exercise and during the subsequent activities of daily living in patients with high-normal to grade 1 hypertension of South-Asian or African descent living in Suriname.

Interventions

BEHAVIORALExercise

aerobic exercise for 30 minutes at 40-60% HRres

Sponsors

KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* • Age 18 - 65 years * Patients with high- normal BP (SBP: 130 - 139 mmHg or and DBP: 85 - 89 mmHg) or stage I hypertension (SBP: 140 - 159 mmHg or DBP: 90 - 99 mmHg) according to the ESC/ESH guidelines \[15\] * Asian or African descent * Do not meet the level of physical activity recommended by the WHO based on self-report \[15\] * Non-medicated patients or patients using a maximum of 2 antihypertensive drugs

Exclusion criteria

* • Functional or mental limitation limiting the correct execution of an exercise bout * History of ischemic stroke, autonomic neuropathy, cardiovascular, renal, or pulmonary disease by self-report * Diabetes type I or II * Pregnancy * The presence of exercise induced signs of myocardial ischemia or complex ventricular arrhythmia during CPET * Patients using three or more antihypertensive drugs or patients with resistant hypertension

Design outcomes

Primary

MeasureTime frameDescription
office blood pressure at 30 minutes post exercise30 minutes postexercsieoffice blood pressure at 30 minutes post exercise

Secondary

MeasureTime frameDescription
daytime blood pressuremean of 8 hours after the interventiondaytime ambulatory blood pressure (8 hours after the intervention)

Countries

Suriname

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026